Q32 Bio Inc. (QTTB) Total Liabilities (2017 - 2026)

Q32 Bio has reported Total Liabilities for 10 years, with the latest figure at $10.0 million in Q2 2026.

• On a quarterly basis, Total Liabilities fell 87.29% year-over-year to $10.0 million in Q2 2026; TTM through Jun 2026 was $10.0 million, a 87.29% decrease from a year earlier, with the FY2025 full-year figure at $19.8 million, down 77.2% from the prior year.
• Total Liabilities was $10.0 million for Q2 2026 at Q32 Bio, down from $17.4 million in the prior quarter.
• The five-year high for Total Liabilities was $118.5 million in Q4 2023, with the low at $10.0 million in Q2 2026.
• Average Total Liabilities over 5 years is $61.7 million, with a median of $52.7 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2026: Total Liabilities jumped 134.76% in 2023, then sank 87.29% in 2026.
• Over 5 years, Total Liabilities stood at $50.5 million in 2022, then surged by 134.76% to $118.5 million in 2023, then dropped by 26.89% to $86.7 million in 2024, then tumbled by 77.2% to $19.8 million in 2025, then tumbled by 49.59% to $10.0 million in 2026.
• The last three Total Liabilities figures came in at $10.0 million (Q2 2026), $17.4 million (Q1 2026), and $19.8 million (Q4 2025), per Business Quant data.